Pharming Group N.V. Other Finance Income Cost
Pharming Group N.V. (PHAR) reported Other Finance Income Cost of -$15.96 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherFinanceIncomeCost · last filed 2026-04-02
EUR
| Period end | Other Finance Income Cost 12 month |
|---|---|
| 2020-12-31 | -28.52M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | -14.25M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | -36.64M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Other Finance Income Cost 12 month |
|---|---|
| 2025-12-31 | -$15.96M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$3.10M 20-F · filed 2026-04-02 |
| 2023-12-31 | -$5.41M 20-F · filed 2026-04-02 |
| 2022-12-31 | -$978.00K 20-F · filed 2025-04-03 |
| 2021-12-31 | $8.71M 20-F · filed 2024-04-04 |
| 2020-12-31 | -$32.59M 20-F · filed 2023-04-05 |
| 2019-12-31 | -$15.96M 20-F · filed 2022-04-06 |